Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Zeitschriftenartikel

Brain pyruvate and 2‐oxoglutarate dehydrogenase complexes are mitochondrial targets of the CoA ester of the Refsum disease marker phytanic acid

MPG-Autoren
/persons/resource/persons84151

Raddatz,  G
Former Department MRZ, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

Volltexte (beschränkter Zugriff)
Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte in PuRe verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Bunik, V., Raddatz, G., Wanders, R., & Reiser, G. (2006). Brain pyruvate and 2‐oxoglutarate dehydrogenase complexes are mitochondrial targets of the CoA ester of the Refsum disease marker phytanic acid. FEBS Letters, 580(14), 3551-3557. doi:10.1016/j.febslet.2006.05.040.


Zitierlink: https://hdl.handle.net/21.11116/0000-0004-83CB-3
Zusammenfassung
Pyruvate and 2‐oxoglutarate dehydrogenase complexes are strongly inhibited by phytanoyl‐CoA (IC50 ≈ 10−6–10−7 M). Palmitoyl‐CoA is 10‐fold less potent. Phytanic or palmitic acids have no inhibitory effect up to 0.3 mM. At the substrate saturation, the acyl‐CoA's affect the first and second enzymatic components of the 2‐oxoglutarate dehydrogenase complex, while the third component is inhibited only at a low saturation with its substrate dihydrolipoamide. Thus, key regulatory branch points of mitochondrial metabolism are targets of a cellular derivative of phytanic acid. Decreased activity of the complexes might therefore contribute to neurological symptoms upon accumulation of phytanic acid in Refsum disease.